Related Experiment Video

Updated: Jun 4, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Special populations: do we need evidence from randomized controlled trials to support the need for respiratory

Bosco Paes1, Paolo Manzoni

  • 1Division of Neonatology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Early Human Development
|January 29, 2011
PubMed

Insights

Infants with medical conditions face high risks from respiratory syncytial virus (RSV) infections. Palivizumab prophylaxis is established for some, but its use in other serious illnesses requires balancing benefits and harms based on evidence.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Infants with congenital abnormalities and impaired physiological mechanisms are at high risk for respiratory morbidity after respiratory syncytial virus (RSV) infection.
  • Established use of RSV prophylaxis (palivizumab) exists for premature infants and those with chronic lung or significant heart disease.

Purpose of the Study:

  • To explore current evidence for palivizumab prophylaxis in infants with various medical disorders.
  • To examine discrepancies between pediatric advisory body recommendations and real-world palivizumab use.

Main Methods:

  • Review of scientific literature on palivizumab efficacy and safety.
  • Analysis of pediatric advisory body guidelines.
  • Comparison of guidelines with clinical practice patterns.

Main Results:

  • Palivizumab prophylaxis is well-established for specific high-risk infant populations based on RCTs.
  • Evidence for prophylaxis in other serious medical conditions is emerging, necessitating a benefit-harm assessment.
  • Differences exist between recommended and actual clinical practice for palivizumab use.

Conclusions:

  • Justification for RSV prophylaxis in infants with serious medical illnesses should be based on scientific literature and a careful balance of treatment benefits and harms.
  • Further research and guideline clarification may be needed to align real-world practice with optimal patient care.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...